DOSHI JITENDRA N 4
4 · CARACO PHARMACEUTICAL LABORATORIES LTD · Filed Aug 2, 2010
Insider Transaction Report
Form 4
DOSHI JITENDRA N
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2010-07-30$6.04/sh−3,700$22,348→ 23,700 total - Sale
Common Stock
2010-07-30$6.06/sh−200$1,212→ 22,700 total - Sale
Common Stock
2010-07-30$6.08/sh−1,100$6,688→ 18,400 total - Sale
Common Stock
2010-07-30$6.09/sh−300$1,827→ 18,100 total - Sale
Common Stock
2010-08-02$6.14/sh−100$614→ 10,000 total - Sale
Common Stock
2010-08-02$6.13/sh−100$613→ 10,100 total - Sale
Common Stock
2010-07-30$6.07/sh−3,200$19,424→ 19,500 total - Sale
Common Stock
2010-08-02$6.15/sh−6,300$38,745→ 3,700 total - Sale
Common Stock
2010-07-30$6.05/sh−800$4,840→ 22,900 total - Sale
Common Stock
2010-08-02$6.04/sh−7,500$45,300→ 10,600 total - Sale
Common Stocki
2010-08-02$6.11/sh−200$1,222→ 10,400 total - Sale
Common Stock
2010-08-02$6.12/sh−200$1,224→ 10,200 total - Sale
Common Stock
2010-08-02$6.16/sh−200$1,232→ 3,500 total
Holdings
- 26,500(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]On June 11, 2010, the reporting person entered into a Rule 10b5-1 trading plan to sell up to 45,000 shares of common stock for estate and tax planning purposes. The reported sales were effected pursuant to such Rule 10b5-1 trading plan.